Farmalis SRL
Farmalis reported total assets of €1.22m at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Aug 2026).
The score of Farmalis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +228 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmalis's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 10 Aug 2022
Farmalis's financial analysis
- Solvency-1.8%sector median: 51.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmalis
Farmalis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0769.950.069
- VAT number
- BE0769950069
- Peppol
- Registered · 0208:0769950069 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Jun 2021
- Registered office
- 5330 Assesse
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Other liberal professions and professional, scientific and technical activities n.e.c. (NACE 74999)
Farmalis (SRL) has been based in Assesse since 2021, active in: other liberal professions and professional, scientific and technical activities n.e.c.. For 2025, it reports a net loss of 19,073 € and equity of −21,721 €; its revenue is not published. Its solvency stands at -1.8%, below the median of its sector (51.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farmalis
Companies in the same business, of comparable size and area, outside its group.
- Carmeuse Ventures Business and other management consultancy activities Ottignies-Louvain-la-Neuve · balance sheet €2.19m
- Tercoren All other professional, scientific and technical activities n.e.c. Flémalle · balance sheet 217,744 €
- Consultes Business and other management consultancy activities Leuven · balance sheet €3.59m
- Pixiel All other professional, scientific and technical activities n.e.c. Namur · balance sheet 618,008 €
- ECELA srl All other professional, scientific and technical activities n.e.c. Profondeville · balance sheet 109,736 €
- Cardihouse All other professional, scientific and technical activities n.e.c. Namur · balance sheet 149,634 €
- Gascap All other professional, scientific and technical activities n.e.c. Orp-Jauche · balance sheet 114,804 €
- Adviesbureau Saga Business and other management consultancy activities Bruges · balance sheet 288,194 €
Frequently asked questions about Farmalis
What is the revenue of Farmalis?
Farmalis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmalis?
In Belgium, the VAT number is the company number prefixed with BE: BE0769950069 for Farmalis, if the company is VAT-registered. Its company number (CBE) is 0769.950.069.
Where is the registered office of Farmalis?
According to the CBE register, the registered office of Farmalis is in 5330 Assesse.
What is the equity of Farmalis?
At the close of the 2025 financial year, the equity of Farmalis amounts to -21,721 €, a solvency of -1.8% of total assets.
Who manages Farmalis?
The register lists 2 active mandates at Farmalis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmalis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →